Globus Medical, Inc.
GMED
$58.17
-$0.08-0.14%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -1.41% | 6.61% | 63.10% | 115.93% | 119.26% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.41% | 6.61% | 63.10% | 115.93% | 119.26% |
| Cost of Revenue | 4.01% | 1.51% | 54.94% | 169.82% | 165.18% |
| Gross Profit | -3.84% | 9.30% | 67.54% | 96.78% | 103.46% |
| SG&A Expenses | -2.36% | 3.54% | 53.96% | 98.27% | 103.14% |
| Depreciation & Amortization | -2.95% | 6.36% | 118.56% | 553.38% | 544.99% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.48% | -0.97% | 53.92% | 130.08% | 139.10% |
| Operating Income | 17.88% | 58.54% | 125.83% | 70.43% | 44.08% |
| Income Before Tax | 1,311.36% | -1.31% | 2,149.78% | -36.28% | -113.54% |
| Income Tax Expenses | 2,057.39% | -118.45% | 238.06% | -6.73% | -110.25% |
| Earnings from Continuing Operations | 1,160.31% | 76.30% | 5,093.99% | -44.97% | -114.49% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1,160.31% | 76.30% | 5,093.99% | -44.97% | -114.49% |
| EBIT | 17.88% | 58.54% | 125.83% | 70.43% | 44.08% |
| EBITDA | 18.49% | 28.76% | 105.58% | 108.00% | 82.71% |
| EPS Basic | 1,149.05% | 77.89% | 4,243.18% | -59.15% | -110.74% |
| Normalized Basic EPS | 54.84% | -4.63% | 95.84% | 10.78% | -24.01% |
| EPS Diluted | 1,126.62% | 82.87% | 4,218.18% | -59.65% | -110.96% |
| Normalized Diluted EPS | 51.49% | -5.90% | 95.27% | 10.86% | -22.55% |
| Average Basic Shares Outstanding | 1.03% | -0.84% | 19.45% | 34.69% | 34.98% |
| Average Diluted Shares Outstanding | 3.26% | 0.50% | 19.80% | 34.58% | 32.45% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |